Dietitians boost GLP-1 therapy success with personalized care and side effect management

Researchers reveal the importance of personalized communication and side effect management in improving outcomes for patients on GLP-1 medications for weight management. The study highlights the critical role of dietitians in guiding lifestyle and dietary changes.

ARCH Venture Partners rises to the top of STAT’s 2023 biotech VC rankings

This article is adapted from the 2023 edition of STAT’s annual report, “Ranking biotech’s top venture capital firms.” ARCH Venture Partners, the long-running investment firm

July 18, 2023

OrbiMed forms biotech with assets from China-based Keymed, enlists former Biohaven exec as CEO

OrbiMed, a longtime biotech funder, created a startup with two bispecific antibodies licensed from a drugmaker in China and put a former Biohaven executive at

July 20, 2024

Structural racism in radiotherapy needs to be addressed to ensure equitable cancer care

Everyone should get quality care, no matter the color of their skin. However, implicit bias, micro-aggressions, and a lack of cultural understanding persist, leading to

November 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.